Dr Melanie Lee CBE steps down as CEO of LifeArc

Dr. Melanie Lee has notified the Board of her decision to step down as Chief Executive Officer,…

LifeArc welcomes news of the UK rejoining Horizon Europe, the EU science research scheme

Today the UK and EU agreed a deal for the UK to associate the world’s largest collaborative…

LifeArc and the Francis Crick Institute partner with five African research institutions to support scientists

LifeArc is partnering with the Francis Crick Institute to invest £7.5m to support African scientists to address unmet…

LifeArc joins Infection Innovation Consortium to help tackle infectious diseases

LifeArc are partnering with Liverpool School of Tropical Medicine (LSTM) to launch a new development fund to…

LifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for Epidermolysis Bullosa

Joint initiative part of LifeArc’s £100 million Translational Challenge to help address rare disease translational science.

Groundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease

Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures

New UK-based research project brings together world-leading institutions to transform care for people living with dementia

Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures

LifeArc strengthens Board of Trustees with new appointments

Dr Terri Cooper, Dr Sameer Mistry and Dr Rima Makarem join LifeArc's Board of Trustees as Non-Executive Directors.

New programme to move potential MND drugs into clinical trials faster

EXPERTS-ALS to screen candidate drugs at scale and identify those that should be fast-tracked to larger clinical trials